RNA binding of Ebola virus VP30 is essential for activating viral transcription

Journal of Virology

Volumn 90, Issue 16, 2016, Pages 7481-7496

  Biedenkopf, Nadine ^a   Schlereth, Julia ^a   Grünweller, Arnold ^a   Becker, Stephan ^a   Hartmanna, Roland K ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOCAPSID PROTEIN; NUCLEOCAPSID PROTEIN VP30; NUCLEOTIDE; PHOSPHOPROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS NUCLEOPROTEIN; ZINC FINGER PROTEIN; PROTEIN BINDING; VIRAL PROTEIN; VIRUS RNA; VP30 PROTEIN, EBOLA VIRUS;

ARTICLE; CONTROLLED STUDY; EBOLAVIRUS; GENE MUTATION; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA BINDING; RNA STRUCTURE; TRANSCRIPTION INITIATION; VIRUS GENOME; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; VIRUS TRANSCRIPTION; CELL LINE; DNA MUTATIONAL ANALYSIS; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; METABOLISM; PHYSIOLOGY;

CELL LINE; DNA MUTATIONAL ANALYSIS; EBOLAVIRUS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; PROTEIN BINDING; RNA, VIRAL; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

EID: 84982217685     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00271-16     Document Type: Article

References (42)

1. Bukreyev AA, Chandran K, Dolnik O, Dye JM, Ebihara H, Leroy EM, Mühlberger E, Netesov SV, Patterson JL, Paweska JT, Saphire EO, Smither SJ, Takada A, Towner JS, Volchov VE, Warren TK, Kuhn JH. 2014. Discussions and decisions of the 2012-2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012-June 2013. Arch Virol 159:821-830. http://dx.doi.org/10.1007 /s00705-013-1846-9.
2. Mahanty S, Bray M. 2004. Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis 4:487-498. http://dx.doi.org/10.1016/S1473-3099(04) 01103-X.
3. WHO Ebola Response Team, Agua-Agum J, Ariyarajah A, Aylward B, Blake IM, Brennan R, Cori A, Donnelly CA, Dorigatti I, Dye C, Eckmanns T, Ferguson NM, Formenty P, Fraser C, Garcia E, Garske T, Hinsley W, Holmes D, Hugonnet S, Iyengar S, Jombart T, Krishnan R, Meijers S, Mills HL, Mohamed Y, Nedjati-Gilani G, Newton E, Nouvellet P, Pelletier L, Perkins D, Riley S, Sagrado M, Schnitzler J, Schumacher D, Shah A, Van Kerkhove MD, Varsaneux O, Wijekoon Kannangarage N. 2015. West African Ebola epidemic after one year- slowing but not yet under control. N Engl J Med 372:584-587. http://dx .doi.org/10.1056/NEJMc1414992.
4. Falzarano D, Geisbert TW, Feldmann H. 2011. Progress in filovirus vaccine development: evaluating the potential for clinical use. Expert Rev Vaccines 10:63-77. http://dx.doi.org/10.1586/erv.10.152.
5. Sanchez A, Kiley MP, Holloway BP, Auperin DD. 1993. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res 29:215-240. http://dx.doi.org/10.1016/0168-1702(93)90063-S.
6. Weik M, Enterlein S, Schlenz K, Mühlberger E. 2005. The Ebola virus genomic replication promoter is bipartite and follows the rule of six. J Virol 79:10660-10671. http://dx.doi.org/10.1128/JVI.79.16.10660-10671.2005.
7. Volchkov VE, Volchkova VA, Chepurnov AA, Blinov VM, Dolnik O, Netesov SV, Feldmann H. 1999. Characterization of the L gene and 5= trailer region of Ebola virus. J Gen Virol 80:355-362. http://dx.doi.org/10.1099/0022-1317-80-2-355.
8. Mühlberger E, Weik M, Volchkov VE, Klenk HD, Becker S. 1999. Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems. J Virol 73: 2333-2342.
9. Mühlberger E. 2007. Filovirus replication and transcription. Future Virol 2:205-215. http://dx.doi.org/10.2217/17460794.2.2.205.
10. Bharat TA, Noda T, Riches JD, Kraehling V, Kolesnikova L, Becker S, Kawaoka Y, Briggs JA. 2012. Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography. Proc Natl Acad Sci U S A 109:4275-4280. http://dx.doi.org/10.1073/pnas.1120453109.
11. Biedenkopf N, Hartlieb B, Hoenen T, Becker S. 2013. Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex: impact on viral transcription and replication. J Biol Chem 288: 11165-11174. http://dx.doi.org/10.1074/jbc.M113.461285.
12. Hartlieb B, Mordof J, Mühlberger E, Klenk HD, Becker S. 2003. Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide. J Biol Chem 278:41830-41836. http://dx.doi.org/10.1074/jbc.M307036200.
13. Hartlieb B, Muziol T, Weissenhorn W, Becker S. 2007. Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association. Proc Natl Acad SciUSA104:624-629. http://dx.doi.org/10.1073/pnas.0606730104.
14. Modrof J, Becker S, Mühlberger E. 2003. Ebola virus transcription activator VP30 is a zinc-binding protein. J Virol 77:3334-3338. http://dx.doi .org/10.1128/JVI.77.5.3334-3338.2003.
15. John SP, Wang T, Steffen S, Longhi S, Schmaljohn CS, Jonsson CB. 2007. Ebola virus VP30 is an RNA binding protein. J Virol 81:8967-8976. http://dx.doi.org/10.1128/JVI.02523-06.
16. Modrof J, Mühlberger E, Klenk HD, Becker S. 2002. Phosphorylation of VP30 impairs Ebola virus transcription. J Biol Chem 227:33099-33104.
17. Weik M, Modrof J, Klenk HD, Becker S, Mühlberger E. 2002. Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation. J Virol 76:8532-8539. http://dx.doi.org/10.1128/JVI.76.17.8532-8539.2002.
18. Martínez MJ, Biedenkopf N, Volchkova V, Hartlieb B, Alzard-Dany N, Reynard O, Becker S, Volchkov V. 2008. Role of Ebola virus VP30 in transcription reinitiation. J Virol 82:12569-12573. http://dx.doi.org/10.1128/JVI.01395-08.
19. Abraham G, Banerjee AK. 1976. Sequential transcription of the genes of vesicular stomatitis virus. Proc Natl Acad Sci U S A 73:1504-1508. http: //dx.doi.org/10.1073/pnas.73.5.1504.
20. Ball LA, White CN. 1976. Order of transcription of genes of vesicular stomatitis virus. Proc Natl Acad Sci U S A 73:442-446. http://dx.doi.org /10.1073/pnas.73.2.442.
21. Hoenen T, Groseth A, Kolesnikova L, Theriault S, Ebihara H, Hartlieb B, Bamberg S, Feldmann H, Ströher U, Becker S. 2006. Infection of naive target cells with virus-like particles: implications for the function of Ebola virus VP24. J Virol 80:7260 -7264. http://dx.doi .org/10.1128/JVI.00051-06.
22. Wenigenrath J, Kolesnikova L, Hoenen T, Mittler E, Becker S. 2010. Establishment and application of an infectious virus-like particle system for Marburg virus. J Gen Virol 91:1325-1334. http://dx.doi.org/10.1099 /vir.0.018226-0.
23. Hoenen T, Jung S, Herwig A, Groseth A, Becker S. 2010. Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription. Virology 403:56-66. http://dx.doi.org/10.1016 /j.virol.2010.04.002.
24. Kolesnikova L, Berhöfer B, Bamberg S, Becker S. 2004. Multivesicular bodies as a platform for formation of the Marburg virus envelope. J Virol 78:12277-12287. http://dx.doi.org/10.1128/JVI.78.22.12277-12287.2004.
25. Schlereth J, Grünweller A, Biedenkopf N, Becker S, Hartmann RK. RNA binding specificity of Ebola virus transcription factor VP30. RNA Biol, in press.
26. Martinez MJ, Volchkova VA, Raoul H, Alazard-Dany N, Reynard O, Volchkov VE. 2011. Role of VP30 phosphorylation in the Ebola virus replication cycle. J Infect Dis 204(Suppl 3):S934-S940. http://dx.doi.org /10.1093/infdis/jir320.
27. Tanner SJ, Ariza A, Richard CA, Kyle HF, Dods RL, Blondot ML, Wu W, Trincao J, Trinh CH, Hiscox JA, Carroll MW, Silman NJ, Eléouet JF, Edwards TA, Barr JN. 2014. Crystal structure of the essential transcription antiterminator M2-1 protein of human respiratory syncytial virus and implications of its phosphorylation. Proc Natl Acad Sci U S A 111:1580-1585. http://dx.doi.org/10.1073/pnas.1317262111.
28. Reid SP, Cárdenas WB, Basler CF. 2005. Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein. Virology 341:179-189. http://dx.doi.org/10.1016/j.virol.2005.06.044.
29. Möller P, Pariente N, Klenk HD, Becker S. 2005. Homo-oligomerization of Marburgvirus VP35 is essential for its function in replication and transcription. J Virol 79:14876-14886. http://dx.doi.org/10.1128/JVI.79.23 .14876-14886.2005.
30. Cárdenas WB, Loo YM, Gale M, Jr, Hartman AL, Kimberlin CR, Martínez-Sobrido L, Saphire EO, Basler CF. 2006. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol 80:5168-5178. http://dx .doi.org/10.1128/JVI.02199-05.
31. Leung DW, Prins KC, Borek DM, Farahbakhsh M, Tufariello JM, Ramanan P, Nix JC, Helgeson LA, Otwinowski Z, Honzatko RB, Basler CF, Amarasinghe GK. 2010. Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35. Nat Struct Mol Biol 17:165-172. http://dx.doi.org/10.1038/nsmb.1765.
32. Zinzula L, Esposito F, Pala D, Tramontano E. 2012. dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35. Antiviral Res 93:354-363. http://dx.doi.org/10.1016/j .antiviral.2012.01.005.
33. Whelan SP, Barr JN, Wertz GW. 2004. Transcription and replication of nonsegmented negative-strand RNA viruses. Curr Top Microbiol Immunol 283:61-119.
34. Fearns R, Collins PL. 1999. Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription. J Virol 73:5852-5864.
35. Wilusz CJ, Wilusz J. 2013. Lsm proteins and Hfq: life at the 3= end. RNA Biol 10:592-601. http://dx.doi.org/10.4161/rna.23695.
36. Leyrat C, Renner M, Harlos K, Huiskonen JT, Grimes JM. 2014. Drastic changes in conformational dynamics of the antiterminator M2-1 regulate transcription efficiency in Pneumovirinae. Elife 3:e02674. http://dx.doi .org/10.7554/eLife.02674.
37. Blondot ML, Dubosclard V, Fix J, Lassoued S, Aumont-Nicaise M, Bontems F, Eléouet JF, Sizun C. 2012. Structure and functional analysis of the RNA-and viral phosphoprotein-binding domain of respiratory syncytial virus M2-1 protein. PLoS Pathog 8(5):e1002734. http://dx.doi .org/10.1371/journal.ppat.1002734.
38. Biedenkopf N, Lier C, Becker S. 2016. Dynamic phosphorylation of VP30 is essential for Ebola virus life cycle. J Virol 90:4914-4925. http://dx.doi .org/10.1128/JVI.03257-15.
39. Bermingham A, Collins PL. 1999. The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proc Natl Acad Sci U S A 96:11259-11264. http://dx.doi.org/10.1073/pnas.96.20.11259.
40. Prins KC, Binning JM, Shabman RS, Leung DW, Amarasinghe GK, Basler CF. 2010. Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function. J Virol 84:10581-10591. http://dx.doi.org/10.1128/JVI.00925-10.
41. Tran TL, Castagné N, Dubosclard V, Noinville S, Koch E, Moudjou M, Henry C, Bernard J, Yeo RP, Eléouet JF. 2009. The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner. J Virol 83:6363-6374. http://dx.doi.org/10.1128/JVI.00335-09.
42. Luthra P, Jordan DS, Leung DW, Amarasinghe GK, Basler CF. 2015. Ebola virus VP35 interaction with dynein LC8 regulates viral RNA synthesis. J Virol 89:5148-5153. http://dx.doi.org/10.1128/JVI.03652-14.